Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry

NCT01402661 is registered in ClinicalTrials.gov with CorEvitas as lead sponsor.

NCT NCT01402661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01402661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry
Lead sponsor
CorEvitas
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 28, 2002
Completion date
December 31, 2100
Enrollment
91,758 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis